Susan O’Brien

2.2k total citations
56 papers, 1.3k citations indexed

About

Susan O’Brien is a scholar working on Genetics, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Susan O’Brien has authored 56 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 24 papers in Hematology and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Susan O’Brien's work include Chronic Lymphocytic Leukemia Research (35 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Susan O’Brien is often cited by papers focused on Chronic Lymphocytic Leukemia Research (35 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Myeloid Leukemia Treatments (14 papers). Susan O’Brien collaborates with scholars based in United States, Finland and Japan. Susan O’Brien's co-authors include Hagop M. Kantarjian, Farhad Ravandi, Jörge E. Cortes, Michael J. Keating, Elihu H. Estey, Francis J. Giles, Emil J. Freireich, Catherine Donaldson, Leila Diamond and Yoshinobu Shimizu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Susan O’Brien

54 papers receiving 1.3k citations

Peers

Susan O’Brien
Donatella Venturelli Italy
M. Y. Gordon United Kingdom
Janet L. Parkin United States
George F. Barker United States
Jason A. Dubovsky United States
Paula Gameiro Portugal
S. Tiong Ong United States
Florence Nguyen‐Khac France
Sheila N.J. Sait United States
Peter D. Emanuel United States
Donatella Venturelli Italy
Susan O’Brien
Citations per year, relative to Susan O’Brien Susan O’Brien (= 1×) peers Donatella Venturelli

Countries citing papers authored by Susan O’Brien

Since Specialization
Citations

This map shows the geographic impact of Susan O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan O’Brien more than expected).

Fields of papers citing papers by Susan O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan O’Brien. The network helps show where Susan O’Brien may publish in the future.

Co-authorship network of co-authors of Susan O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Susan O’Brien. A scholar is included among the top collaborators of Susan O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan O’Brien. Susan O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jaalouk, Diana E., Carlos E. Bueso‐Ramos, Laura Bover, et al.. (2015). Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens. Clinical Cancer Research. 21(13). 3041–3051. 11 indexed citations
2.
Daver, Naval & Susan O’Brien. (2013). Novel Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia – A Focus on Emerging Monoclonal Antibodies. Current Hematologic Malignancy Reports. 8(2). 123–131. 17 indexed citations
3.
Strati, Paolo, Alessandra Ferrajoli, Susan Lerner, et al.. (2013). Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemia. Leukemia & lymphoma. 55(4). 828–833. 8 indexed citations
4.
5.
Kantarjian, Hagop, J. Shan, Alfonso Quintás‐Cardama, et al.. (2012). Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy. Haematologica. 97(7). 1029–1035. 63 indexed citations
6.
O’Brien, Susan & Anders Österborg. (2010). Ofatumumab: A New CD20 Monoclonal Antibody Therapy for B-Cell Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma & Leukemia. 10(5). 361–368. 19 indexed citations
7.
Jaalouk, Diana E., Carlos E. Bueso‐Ramos, Amado J. Zurita, et al.. (2010). Targeting neuropilin-1 in human leukemia and lymphoma. Blood. 117(3). 920–927. 86 indexed citations
8.
Kantarjian, Hagop M., et al.. (2009). Plasma levels of JAK2 mRNA in patients with chronic myeloproliferative diseases with and without V617F mutation: implications for prognosis and disease biology. International Journal of Laboratory Hematology. 32(1p2). 95–102. 3 indexed citations
9.
Yeh, Chen-Hsiung, Zhong Zhang, Jörge E. Cortes, et al.. (2008). Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia. Leukemia Research. 33(2). 212–217. 23 indexed citations
10.
Takahashi, Shunsuke, Diana E. Jaalouk, Susan O’Brien, et al.. (2008). Combinatorial Targeting of the Macropinocytotic Pathway in Leukemia and Lymphoma Cells. Journal of Biological Chemistry. 283(17). 11752–11762. 45 indexed citations
11.
Thomas, Deborah A., Susan O’Brien, Jörge E. Cortes, & Hagop M. Kantarjian. (2007). New approaches to the management of Philadelphia chromosome-positive acute lymphocytic leukemia. Current Hematologic Malignancy Reports. 2(3). 183–189. 1 indexed citations
12.
Ravandi, Farhad & Susan O’Brien. (2005). Immune defects in patients with chronic lymphocytic leukemia. Cancer Immunology Immunotherapy. 55(2). 197–209. 101 indexed citations
13.
14.
Keating, Michael J., Terry L. Smith, Susan Lerner, et al.. (2000). Prediction of Prognosis Following Fludarabine Used as Secondary Therapy for Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 37(1-2). 71–85. 29 indexed citations
15.
O’Brien, Susan. (2000). Pilot Study of Rituximab in Refractory or Relapsed Hairy Cell Leukemia. 11 indexed citations
16.
Cortes, Jörge E., Susan O’Brien, Elihu H. Estey, et al.. (1999). Phase I study of liposomal daunorubicin in patients with acute leukemia. Investigational New Drugs. 17(1). 81–87. 45 indexed citations
17.
18.
Estey, Elihu H., Francis J. Giles, Hagop M. Kantarjian, et al.. (1999). Molecular Remissions Induced by Liposomal-Encapsulated All-Trans Retinoic Acid in Newly Diagnosed Acute Promyelocytic Leukemia. Blood. 94(7). 2230–2235. 85 indexed citations
19.
O’Brien, Susan, Hagop M. Kantarjian, Charles Koller, et al.. (1999). Sequential Homoharringtonine and Interferon- in the Treatment of Early Chronic Phase Chronic Myelogenous Leukemia. Blood. 93(12). 4149–4153. 79 indexed citations
20.
Keating, Michael J., Elihu H. Estey, Susan O’Brien, et al.. (1990). Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia. Cancer. 65(1). 5–8. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donatella Venturelli Breakdown of academic impact, for papers by M. Y. Gordon Breakdown of academic impact, for papers by Janet L. Parkin Breakdown of academic impact, for papers by George F. Barker Breakdown of academic impact, for papers by Jason A. Dubovsky Breakdown of academic impact, for papers by Paula Gameiro Breakdown of academic impact, for papers by S. Tiong Ong Breakdown of academic impact, for papers by Florence Nguyen‐Khac Breakdown of academic impact, for papers by Sheila N.J. Sait Breakdown of academic impact, for papers by Peter D. Emanuel
Rankless by CCL
2026